Lack of association between the Pro12Ala polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in the Qatari consanguineous population

Acta Diabetologica

Volumn 45, Issue 1, 2008, Pages 15-21

  Badii, Ramin ^a   Bener, Abdulbari ^a,b   Zirie, Mahmoud ^c   Al Rikabi, Ammar ^a   Simsek, Mehmet ^d   Al Hamaq, Abdulla O A A ^e   Ghoussaini, Maya ^f   Froguel, Philippe ^f   Wareham, Nick J ^g  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HAMAD GENERAL HOSPITAL   (Qatar)

^d SULTAN QABOOS UNIVERSITY   (Oman)

^e QATAR FOUNDATION   (Qatar)

^f INSTITUT PASTEUR DE LILLE   (France)

^g MRC EPIDEMIOLOGY UNIT   (United Kingdom)

Author keywords

Consanguinity; Lifestyle; Obesity; PPAR 2 gene; Pro12Ala polymorphism; Qatar; Risk factors; Type 2 diabetes mellitus

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; ETHNICITY; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; HEALTH STATUS; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2 GENE; QATAR; QUESTIONNAIRE; AMINO ACID SUBSTITUTION; BLOOD; CONSANGUINITY; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PHENOTYPE; REFERENCE VALUE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALANINE; AMINO ACID SUBSTITUTION; BODY MASS INDEX; CONSANGUINITY; DIABETES MELLITUS, TYPE 2; DNA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; PROLINE; QATAR; REFERENCE VALUES;

EID: 39049159123     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0013-8     Document Type: Article

References (32)

1. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R (2003) Molecular mechanism of insulin resistance and obesity. Exp Biol Med 228:1111-1117
2. Stumvoll M, Haring H (2002) Perspective in diabetes: The peroxisome proliferators-activated receptor γ2 Pro12Ala polymorphism. Diabetes 50:2341-2347
3. Barroso I, Gurnell M, Crowley VEF et al (1999) Dominant negative mutations in human PPAR γ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402(6764):880-883
4. Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, Kotani R, Yamada K, Sakata M, Kurohara M, Wiyono P, Asdie H, Sakaue M, Taniguchi H, Yokono K (2005) A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia. Diabetes Metab Res Rev 21:465-469
5. Tavares V, Hirata RD, Rodrigues AC, Monte O, Salles JE, Scalissi N, Speranza AC, Hirata MH (2005) Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus. Diabetes Obes Metab 7:605-611
6. Giusti V, Verdumo C, Sutter M, Gaillard RC, Burckhardt P, Pralong F (2003) Expression of PPAR γ 2 in visceral and subcutaneous adipose tissue of obese women. Diabetes 52:1673-1676
7. Fajas L, Auboeuf D, Raspe E et al (1997) The organization, promoter analysis, and expression of the human PPAR γ gene. J Biol Chem 272:18779-18789
8. Bener A, Zirie M, Al-Rikabi R (2005) Genetics, obesity and environmental risk factors associated with type 2 diabetes. Croat Med J 46:302-307
9. Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clement K, Charles MA, Tauber M, Weill J, Froguel P (2005) Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet 6:11
10. Deeb SS, fajas L, Nemoto M et al (2004) A Pro12Ala substitution in PPAR γ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287
11. Frederiksen L, Broadbaek K, Fenger M et al (2002) Comment: studies of the Pro12Ala polymorphism of the PPAR gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab 87:3989-3992
12. Mori H, Ikegami H, Kawaguchi Y et al (2001) Brief genetics report the Pro12 → Ala substitution in PPAR γ is associated with resistance to development of diabetes in the general population possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes 50:891-894
13. Altshuler D, Hirschhorn JN, Klannenmark M et al (2000) The common PPAR Pro12ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
14. Masud S, Ye S, SAS group (2003) Effect of the peroxisome proliferators activated receptor γ2 Pro12Ala variant on body mass index: a meta-analysis. J Med Genet 40:773-780
15. Beamer BA, Yen C-J, Andersen RE et al (1998) Brief genetics report: association of the Pro12Ala variant in the PPAR γ2 gene with obesity in two Caucasian populations. Diabetes 47:1806-1809
16. Tai ES, Corella D, Yap MD et al (2004) Differential effects of the C1431T and Pro12Ala PPAR γ2 variants on plasma lipids and diabetes risk in an Asian population. J Lipids Res 45:674-685
17. Oh EY, Min KM, Chung JH et al (2000) Significance of Pro12Ala mutation in peroxisome proliferators-activated receptor γ2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab 85:1801-1804
18. Muller YL, Bogardus C, Beamer BA, Shuldiner AR, Baier LJ (2003) A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. Diabetes 52:1864-1871
19. Rosmond R, Chagnon M, Bouchard C (2003) The Pro12Ala PPAR γ2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes Metab Res Rev 19:159-163
20. 2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. J Eur Endocrinol 147:495-501
21. American Diabetes Association (2004) Diagnosis classification of diabetes mellitus. Diabetes Care 27:S5-S10
22. World Health Organization (1999) International society of hypertension guidelines for the management of hypertension. J Hypertens 17:151-182
23. Stumvoll M, Haring H (2002) Perspectives in diabetes: the peroxisome proliferator-activated receptor-γ 2 Pro12Ala polymorphism. Diabetes 51:2341-2347
24. de Pablos-Velasco PL, Martinez-Martin FJ, Rodriguez-Perez A et al (2001) Prevalence and determinants of diabetes mellitus and glucose intolerance in a Canarian Caucasian population comparison of the 1997 ADA and the 1985 WHO criteria. The Guia study. Diabet Med 18:235-341
25. Lindi V, Sivenius K, Niskanen L, Laakso M, Uusitupa MIJ (2001) Effect of the Pro12Ala polymorphism of the PPAR γ2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia 44:925-926
26. Hasstedt SJ, Ren Q-F, teng K, Elbein SC (2001) Effect of the peroxisome proliferators-activated receptor-γ2 Pro12Ala variant on obesity, glucose homeostasis, and blood pressure in members of familial Type2 diabetic kindreds. J Clin Endocrinol Metab 86:536-541
27. Luan J, Browne PO, Harding AH et al (2001) Evidence for gene-nutrient interaction at the PPAR γ locus. Diabetes 50:686-689
28. Rodriguez-Esparragon FJ, Rodriguez-Perez JC, Macias-Reyes A et al (2003) Peroxisome proliferators-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are associated with essential hypertension. J Hypertens 21:1649-1655
29. Zouari Bouassida K, Chouchane L, Jellouli K, Cherif S, Haddad S, Gabbouj S, Danguir J (2005) The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients. Diabetes Metab 31:119-23
30. Sutanegara D, Darmono, Budhiarta AAG (2000) The epidemiology and management of diabetes mellitus in Indonesia. Diabetes Res Clin Pract 50(Suppl 2):S9-S16
31. Bener A, Alali KA (2006) Consanguineous marriage in a newly developed country: the Qatari population. J Biosoc Sci 38:239-246
32. Bener A, Hussain R (2006) Consanguineous unions and child health in Qatar. Paediatr Perinat Epidemiol 20:372-378